Johnson & Johnson France


Johnson & Johnson France is owned by Johnson & Johnson EMEA.

Johnson & Johnson is one of the...

Johnson & Johnson is a company listed under the stock ticker JNJ (US).

Johnson & Johnson has a direct presence in 25 countries.

Johnson & Johnson has 67 subsidiaries including Auris Health, DePuy Synthes and Ethicon.

They are in:

Acquisition, funding and merger involving Johnson & Johnson.


View the org chart displaying its 3 main executives

Most searched biographies at Johnson & Johnson France
Popular executive movements at Johnson & Johnson
  • Mathai Mammen, Executive Vice President, Global Head of R&D Pharmaceutical, has left the company  (posted on August 9 2022).
  • Bill Hait who was Executive Vice President and Chief External Innovation, Medical Safety & Global Public Health Officer, becomes Interim Head of the Pharmaceutical Research and Development Organization  (posted on August 9 2022).
  • Michael Ullmann, Executive Vice President and General Counsel, will retire on Dec. 31, 2022  (posted on July 19 2022).

Click here to view some more movements at Johnson & Johnson

Create an alert
to follow the executive moves at Johnson & Johnson France.


Johnson & Johnson has 1,989 competitors including Pfizer (United States (USA)), Sanofi (France) and Roche (Switzerland).

Popular M&A news in Pharmaceuticals
Popular contacts in Pharmaceuticals

Learn more about the Pharmaceuticals industry >


Press releases by Johnson & Johnson France
Social media about Johnson & Johnson France

The most constantly updated executive directory.



Learn about your clients' org charts. Understand their industries and their competitors.



View the executives' biographies. Contact the executives through our email platform.



Select key words to follow your clients. Receive alerts when executive movements happen.


Track your clients

File your clients in folders. Add private notes. Download our data in Excel on your PC.